BCDA
BioCardia, Inc. Common StockRecent alerts on BCDA
All signals →
Insider trade
Purchase by Altman Peter (President and CEO)
11d ago
Insider trade
Purchase by Altman Peter (President and CEO)
11d ago
Insider trade
Purchase by Altman Peter (President and CEO)
14d ago
Insider trade
Purchase by Altman Peter (President and CEO)
17d ago
News
BioCardia outlines Japan Shonin filing in ~7 months and targets ~19-month path to approval for CardiAMP
17d ago
SEC filing
BCDA Reports Q1 2026 Net Loss $2.3M, Cash $0.95M
18d ago
Insider trade
Purchase by Peter Altman (President and CEO)
33d ago
Insider trade
Purchase by Peter Altman (President and CEO)
39d ago
Insider trade
Purchase by Peter Altman (President and CEO)
40d ago
SEC filing
BCDA Delisted: $895K Equity Below $2.5M Nasdaq Minimum, 180-Day Plan Deadline May 25, 2026
47d ago
News
BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit
69d ago
SEC filing
BCDA Reports $12.4M Revenue, $0.08 EPS, Announces CardiAMP HF II Trial Expansion, Japan PMDA Consultation, Euro PCR Presentation
69d ago
Insider trade
Purchase by Peter Altman (President and CEO)
104d ago
Insider trade
Purchase by Peter Altman
104d ago
SEC filing
BCDA Completes Pre-Submission Under Q-Subm Process
112d ago
SEC filing
Other Events
119d ago
Short volume
Short volume 78% of volume (3.6σ)
125d ago
SEC filing
BCDA Advances CardiAMP Heart Failure Cell Therapy, Progresses to PMDA Consultation in Japan
168d ago
Get push alerts for BCDA
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS